Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	Anti-inflammatory Pain Relief Gel Diclofenac sodium 10mg/g Topical gel PSM Healthcare Limited trading as API Consumer Brands PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	Aspec Aspirin 100mg Enteric coated tablet Medreich New Zealand Limited Medreich Limited, Bangalore, India
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	Medreich Aspirin EC Aspirin 100mg Enteric coated tablet Medreich New Zealand Limited Medreich Limited, Bangalore, India
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	Pravastatin Mylan Pravastatin sodium 10mg Tablet Mylan New Zealand Limited Intas Pharmaceuticals Limited, Sanand, India
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	Pravastatin Mylan Pravastatin sodium 20mg Tablet Mylan New Zealand Limited Intas Pharmaceuticals Limited, Sanand, India
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	Pravastatin Mylan Pravastatin sodium 40mg Tablet Mylan New Zealand Limited Intas Pharmaceuticals Limited, Sanand, India

Dated this 17th day of April 2019.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule